Skip to main content

Dr. Bear is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Bear's full profile

Already have an account?

Education & Training

  • Indiana University School of Medicine
    Indiana University School of MedicineMSc, Clinical Research, 2008 - 2012
  • Indiana University School of Medicine
    Indiana University School of MedicineFellowship, Pediatric Hematology/Oncology, 2007 - 2010
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Pediatrics, 2004 - 2007
  • Pennsylvania State University College of Medicine
    Pennsylvania State University College of MedicineClass of 2004

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2005 - 2025
  • American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • A Standardized autopsy procurement allow for the comprehensive study of DIPG biology  
    Madhuri Kambhampati,Jennifer P Perez,Sridevi Yadavilli, Amanda M. Saratsis,Ashley D. Hill, Cheng-Ying Ho, Eshini Panditharatna,Melissa Markel, Roger J. Packer,Javad N..., Oncotarget, 5/2015

Abstracts/Posters

  • A phase 2 study of abemaciclib in patients with leptomeningeal metastases secondary to HR+, HER2- breast cancer [abstract]. In: Proceedings of the 2018 San Antonio Bre...
    Tolaney SM, Sahebjam S, Le Rhun E, Lin NU, Markel Bear M, Yang Z, Chen Y, Anders CK, Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
  • nextMONARCH 1: Phase 2 study of abemaciclib plus tamoxifen or abemaciclib alone in HR+, HER2- advanced breast cancer [abstract].
    Hamilton E, Cortes J, Dieras V, Ozyilkan O, Chen S-C, Petrakova K, Manikhas A, Jerusalem G, Hegg R, Lu Y, Bear MM, Johnston EL, Martin M, In: Proceedings of the 2018 San Antonio Breast Cancer Symposium;, 12/2018
  • Examining Urinary Biomarkers of Cisplatin Nephrotoxicity in Children.
    Markel M, Ross J, Then J, Renbarger J., Pediatric Blood and Cancer., ASPHO, 2016

Hospital Affiliations